In This Section:

◄
►

Cardiomyopathy

Welcome to our featured section on cardiomyopathy

Click here to take the CME-accredited courses. 

This educational hub pulls together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub will be CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos. 

 

See more ▼
Close X
Other videos you might like

Section Advisor

Professor Perry Elliott

Chair, Cardiovascular Medicine, University College London, and Head, Clinical Research, UCL Institute of Cardiovascular Science, London, UK

Supported through an educational grant from Bristol Myers Squibb.

Broadcast

Updates in HCM Management: ESC Cardiomyopathy Guidelines 2023

Elena Arbelo, Juan-Pablo Kaski,

Watch time: 59m 7s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Video

HFA 2023 Late-breaking Science Highlights

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Video

HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana,

Watch time: 3m 11s
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Video

HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Ahmad Masri ,

Watch time: 6m 54s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Video

HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

Video Series

e-SPACE Cardio-Renal-Metabolic 2023

Fausto J Pinto, John Spertus, , et al

Watch time: 16h 19m 46s (19 videos)

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

HFSA 22: REDWOOD-HCM OLE: KCCQ Scores In Pts With HCM Treated With Aficamten

Video

HFSA 22: KCCQ Scores In Pts With HCM Treated With Aficamten

Sara Saberi,

Watch time: 15m 24s

Broadcast

Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Video Series

e-SPACE CRM 2022

Andrew JS Coats, Stefan Anker,

Watch time: 23h 16m 49s (126 videos)

Recent Videos

ESC 23: ATTRibute-CM Trial

Video

ESC 23: ATTRibute-CM Trial

Julian Gillmore,

Watch time: 4m 39s

Broadcast

Updates in HCM Management: ESC Cardiomyopathy Guidelines 2023

Elena Arbelo, Juan-Pablo Kaski,

Watch time: 59m 7s
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Video

Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Marianna Fontana,

Watch time: 8m 1s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Video

HFA 2023 Late-breaking Science Highlights

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Video

HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana,

Watch time: 3m 11s
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Video

HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Ahmad Masri ,

Watch time: 6m 54s

Radcliffe Content

Chest Pain in the Cancer Patient

European Cardiology Review 2022;17:e15.